Danaher prices Euro-denominated senior notes offering, expects to receive net proceeds of €2.68 billion

NewsGuard 100/100 Score

Danaher Corporation (NYSE: DHR) ("Danaher") announced today that its wholly-owned subsidiary, DH Europe Finance S.A. ("Danaher International"), has priced an offering of:

  • €500 million principal amount of floating rate senior notes due 2017 at an offering price of 100.000% of the principal amount;
  • €600 million principal amount of 1.000% senior notes due 2019 at an offering price of 99.696% of the principal amount;
  • €800 million principal amount of 1.700% senior notes due 2022 at an offering price of 99.651% of the principal amount; and
  • €800 million principal amount of 2.500% senior notes due 2025 at an offering price of 99.878% of the principal amount.

Danaher expects to receive net proceeds, after estimated expenses and the underwriters' discounts and commissions, of approximately €2.68 billion. Danaher anticipates using the net proceeds from the offering to pay a portion of the purchase price of the previously announced acquisition of Pall Corporation and for general corporate purposes. The senior notes will be fully and unconditionally guaranteed on a senior unsecured basis by Danaher. The offering is expected to close on July 8, 2015.

Deutsche Bank AG, London Branch, Merrill Lynch International, BNP Paribas, HSBC Securities (USA) Inc. and Morgan Stanley & Co. International plc are acting as joint book-running managers for the offering.

The offering is being made pursuant to an effective shelf registration statement on file with the U.S. Securities and Exchange Commission.

The offering of senior notes may be made only by means of a prospectus and prospectus supplement. A copy of the prospectus and prospectus supplement relating to the securities can be obtained from Deutsche Bank AG, London Branch at Winchester House, 1 Great Winchester Street, London EC2N 2DB, United Kingdom, Attention: GRS, Facsimile: +44 207 545 4455; and from Merrill Lynch International at 2 King Edward Street, London EC1A 1HQ, United Kingdom, Attention: Syndicate Desk, Facsimile +44 207 995 0048.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.